Founder of Regulon, the inventor of Lipoplatin and CEO
Teni holds a B.Sc. degree in Chemistry from the Aristotelian University of Thessaloniki and a Ph.D. from the Southwestern Medical School in Dallas, Texas in Biochemistry. As a EMBO postdoctoral fellow, Teni studied at the Swiss Institute for Experimental Cancer Research in Epalinges sur Lausanne.
Chief Financial Officer (CFO)
He joined Regulon in 2016. Before that, he had a long career in Banking and Asset Management. He was a Senior Director of Investment Management at Eurobank Asset Management, and prior to that was the Head of Credit and ABS Trading at Eurobank. He has an MBA from Imperial College, a BSc. in Computer Science from University of Athens with Honors and a BA in Economics from University of Athens.
Member of the BOD
He has represented Greece in all major virus strikes at a European level. He is also a member of the EOF (Greek FDA) committee on biological drugs. As a director of the Papanikolaou Research Center at Agios Savvas Anticancer Hospital in Athens for 25 years he collaborated with almost every oncologist in the country providing expertise assistance with tissue culture other oncology studies.
Chief Scientific Officer
He obtained his BS in Chemistry from Athens University and his PhD from Drexel University in Philadelphia. In 1973, after three years with Amoco Chemicals and Motor Oil (Hellas), he joined the Institute of Physical Chemistry at NCSR “Demokritos”, where he was elected Director for the periods 1994-1999 and 2001-2007 while currently he is collaborating with this Institute. He was elected, in the periods 1994-1996 and 2005-2006 Vice President of Board of NCSR Demokritos. From 2002 he is consultant at Regulon, Inc.
She has graduated from the Medical School of the Kapodistrian University of Athens, Greece. Following a graduate program, she has worked with physicians of different expertize in central hospitals of Athens. She joined Regulon in 2010 as a Medical Officer, working intensively coordinating clinical studies, communicating with oncologists and initiating sites worldwide, preparing all necessary study reference documents (protocols, ICFs, CRFs), as well as reports for local Regulatory Authorities.
She has graduated from the Medical School of L Aquila, Italy. Specialized in Radiology (Conventional Radiology, Ultrasonography, Interventional Radiology, CT and MRI) at Evangelismos General Hospital (Athens) and in Pediatric Radiology at Paidon Pentelis Hospital (Athens).
Senior VP, Business Development
Ted is responsible for the Corporate office of Regulon in Melville, New York.
A flourishing financier and real estate developer in the U.S. and abroad, Ted Doukas began his investment career in Long Island NY, where acquiring first class office, retail and residential properties throughout affluent Nassau and Suffolk Counties, he became one of the largest individual property in the area’s history. As volatility in the real estate market spread, Doukas’ abilities to develop and turnaround complex projects has led him to extensively expand his work into the beleaguered markets. Born in Greece, Doukas studied Medicine for two years at the University of Pisa in Italy before coming to the U.S. where he was educated in Business at New York Institute of Technology. Ted is recognized throughout a myriad of industries for his creative thinking and ability to profitably implement critical growth-oriented policies.
Member of the BOD
Dr. Karipi has been responsible for the introduction of Lipoplatin™ at the Sotiria Pulmonary Disease Hospital in a Phase III study as first line against non-small cell lung cancer. She holds her Medical degree from the Medical School of Athens, Greece and her specialization at the 4th Clinic of the Sotiria Pulmonary Disease Hospital. She has represented Regulon in several business meetings.
Information Technology & Bioinformatics Specialist
She holds a main degree in Computer Science and received her M.Sc. in Bioinformatics from the National and Kapodistrian University of Athens, Department of Biology. In her Master Thesis she worked upon the computational identification of novel miRNAs and the prediction of their functional role connected to immune system-related diseases. She has working experience in Databases and Web Design & Development and she is being trained in Computer Aided Drug Design.
Information Technology Specialist
He has a critical mind in presenting our technology and he masters electronic data management including data on clinical studies and presentation of documents. Niko possesses also web designing skills. His recent achievement is the setting of a web program for electronic data capture on patients enrolled in Lipoplatin’s pivotal clinical trials